The reiteration of the 'Sector Perform' rating and maintenance of the $8 price target by RBC Capital suggests a neutral outlook on GoodRx Holdings. This indicates that the analyst believes the stock is fairly valued at its current price, implying a stable short-term performance. However, without significant positive or negative catalysts mentioned, the impact on the stock price is likely to be minimal in the short term.